Tenofovir Alafenamide

What is Tenofovir Alafenamide?

Tenofovir alafenamide is an antiviral medication belonging to a class of drugs called nucleotide reverse transcriptase inhibitors (a subtype of NRTIs). It is a newer formulation designed to deliver the active form of tenofovir more efficiently to cells, which allows for a lower dose compared to older tenofovir formulations while aiming to reduce certain long-term side effects.

Common approved uses include:

• Treatment of HIV-1 infection, used in combination with other antiretroviral medications
• Treatment of chronic hepatitis B virus (HBV) infection in adults and certain adolescent patients with compensated liver function

Available formulations and strengths:

• Oral tablets (available in different strengths depending on whether the product is intended for HIV treatment, hepatitis B treatment, or as part of a combination product)
• Often included as one component within fixed-dose combination tablets alongside other antiretroviral agents

This medication does not cure HIV or hepatitis B. It helps control viral replication and reduce liver or immune damage when taken consistently as directed.

What is the Recommended Dosage of Tenofovir Alafenamide?

Dosage varies based on:

• Condition being treated (HIV treatment regimens differ from hepatitis B treatment regimens)
• Age, since pediatric and adolescent dosing may differ from adult dosing
• Body weight, particularly in younger patients
• Kidney function, since dosing recommendations depend on the degree of kidney impairment
• Liver function, particularly for patients with hepatitis B

Available dosage form: Oral tablet, typically taken once daily, often alongside food depending on the specific product.

Because the correct dose depends on the condition being treated and individual organ function, patients should never adjust their dose independently. Always follow the exact dosing schedule provided by a licensed medical specialist.

How Tenofovir Alafenamide Works

Tenofovir alafenamide is a “prodrug,” meaning it is converted inside the body into its active form after entering cells. Once activated, it interferes with an enzyme called reverse transcriptase, which HIV and hepatitis B virus need to copy their genetic material.

By blocking this enzyme, the medication prevents the virus from multiplying effectively. Because tenofovir alafenamide is designed to concentrate the active drug more efficiently within cells, it can achieve similar antiviral effects at a lower circulating dose, which may reduce certain side effects associated with older tenofovir formulations.

This medication manages HIV and hepatitis B infections long-term but does not eliminate the virus from the body.

Is a Prescription Required to Buy Tenofovir Alafenamide Online?

Yes. Tenofovir alafenamide is a prescription-only medication and should never be purchased or used without medical supervision.

Patients should consult with:

• An infectious disease specialist or HIV care provider (for HIV treatment)
• A hepatologist or gastroenterologist specializing in liver disease (for hepatitis B treatment)

Important safety notes:

• Only obtain this medication from a licensed pharmacy that requires a valid prescription
• Avoid unregulated online sellers, as counterfeit antiviral products pose serious health risks
• Never use veterinary or non-human formulations of any medication
• Different tenofovir products (alafenamide vs. other formulations) are not automatically interchangeable; use only as prescribed

Side Effects of Tenofovir Alafenamide

Common Side Effects

• Nausea
• Headache
• Fatigue
• Diarrhea
• Abdominal discomfort
• Changes in body fat distribution (mild, over time)

Serious Side Effects

• Signs of kidney problems (changes in urination, swelling in legs or ankles, unusual fatigue)
• Symptoms of lactic acidosis (rapid breathing, unusual muscle pain, stomach discomfort, feeling unusually cold)
• Signs of liver problems, including worsening of hepatitis B after stopping the medication (yellowing of skin or eyes, dark urine, severe fatigue)
• Bone-related changes, including decreased bone mineral density with long-term use
• Signs of a severe allergic reaction (facial or throat swelling, difficulty breathing)
• Immune reconstitution syndrome symptoms (new or worsening signs of infection shortly after starting treatment, in patients with advanced HIV)

Patients experiencing any serious symptoms should seek immediate medical attention. Patients with hepatitis B should never stop this medication abruptly, as doing so can cause a serious flare-up of liver disease; any changes must be supervised by a specialist.

Drug Interactions

Certain medications and substances can interact with tenofovir alafenamide, affecting how well it works or increasing the risk of side effects. Categories that may interact include:

• Medications that affect a specific liver transport protein system, which can alter how this drug is absorbed
• Certain anti-seizure medications
• Certain antibiotics and antifungal medications
• St. John’s Wort and other herbal supplements, which may reduce effectiveness
• Over-the-counter antacids or supplements containing certain minerals, which may affect absorption depending on timing

Patients should provide their licensed medical specialist with a complete and current list of all prescription medications, over-the-counter drugs, vitamins, and herbal supplements before starting treatment.

Safety & Important Considerations

• Kidney disease precautions: Kidney function should be assessed before starting treatment and monitored periodically, as dosing may need adjustment or the medication may not be suitable for patients with significant kidney impairment.
• Liver disease precautions: Patients with hepatitis B require close monitoring, both during treatment and after stopping, due to the risk of disease flare-up.
• Bone health: Long-term use may be associated with changes in bone mineral density; monitoring may be recommended for patients with a history of bone fractures or osteoporosis risk factors.
• Pregnancy and breastfeeding: Patients who are pregnant, planning pregnancy, or breastfeeding should discuss individual risks and benefits with their specialist.
• Age-related considerations: Dosing and safety have been studied differently across age groups; pediatric use depends on age and weight thresholds.
• Monitoring requirements: Regular blood tests are typically needed to monitor kidney function, liver function, and viral levels throughout treatment.
• FDA safety warnings: This medication carries warnings regarding lactic acidosis, liver problems, and the risk of hepatitis B flare-ups after discontinuation.

Who This Medication Is For

This medication is generally prescribed for individuals diagnosed with HIV-1 infection requiring combination antiretroviral therapy, or individuals with chronic hepatitis B who have compensated liver function. Treatment is individualized based on the specific diagnosis, kidney and liver function, and overall health, as determined by the appropriate specialist.

Who Should Not Take Tenofovir Alafenamide

This medication may not be appropriate for individuals who:

• Have a known hypersensitivity to tenofovir alafenamide or related components
• Have severe kidney impairment, depending on the specific product and clinical guidance
• Are being treated for hepatitis B and also have undiagnosed or untreated HIV infection, since treating hepatitis B alone in a patient with HIV can lead to HIV drug resistance

A full medical history review, including kidney function testing and HIV status when relevant, is necessary before starting treatment to identify any contraindications or precautions.

What to Do If You Miss a Dose

If a dose is missed, take it as soon as remembered unless it is close to the time of the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule.

Do not double the dose to make up for a missed one. For patients being treated for hepatitis B, consistent dosing is especially important, and missed doses or stopping treatment without medical guidance can lead to serious liver complications. Contact a licensed medical specialist if unsure how to proceed.

Related medications to Tenofovir Alafenamide

Tenofovir Alafenamide is a tenofovir prodrug used in specific antiviral regimens. A related page is Tenofovir Disoproxil Fumarate, but the two formulations differ in dosing, pharmacology, product combinations, and safety considerations and should not be treated as interchangeable.

Storage Instructions

• Store at room temperature, away from excessive heat or cold
• Keep in the original container, protected from moisture and light
• Keep out of reach of children and pets
• Do not use expired medication

Disclaimer:

This page is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult a licensed infectious disease specialist, hepatologist, or qualified healthcare provider before starting, changing, or stopping this medication. Treatment decisions must be based on a full clinical evaluation by a qualified specialist.